ATC Abstracts

American Transplant Congress abstracts

2016 American Transplant Congress

June 11-15, 2016 in Boston, MA

View by Title View Sessions
View by Date

Saturday, June 11, 2016

5:30pm-7:30pm
Clinical Outcome of Elderly Living Kidney Donors: A Single-Center Study in Japan.

J. Hasegawa, K. Unagami, M. Okumi, K. Omoto, M. Inui, H. Ishida, K. Tanabe.

Poster Session A: Kidney Donor Outcomes  •  Halls C&D
5:30pm-7:30pm
Clinical Outcome on Kidney Retransplantation in Comparison with First Kidney Transplantation in Korea – Nationwide Cohort Study.

J. Kim,1,2 T. Ban,1,2 B. Jung,1,2 B. Choi,1,2 C. Park,1,2 C. Yang,1,2 Y.-S. Kim.1,2

Poster Session A: Poster Session III: Kidney Complications-Other  •  Halls C&D
5:30pm-7:30pm
Clinical Significance of Solitary Pulmonary Nodules in Liver Transplant Recipients with Hepatocellular Carcinoma.

O. Serrano,1 A. Bangdiwala,2 D. Vock,2 V. Kirchner,1 K. Yadav,1 A. Pugalendhi,1 E. Minja,1 T. Dunn,1 E. Finger,1 A. Matas,1 R. Kandaswamy,1 W. Payne,1 T. Pruett,1 S. Chinnakotla.1

Poster Session A: Liver - Hepatocellular Carcinoma and Cholangiocarcinoma Malignancies  •  Halls C&D
5:30pm-7:30pm
Clinical Usefulness of mRECIST Response to Chemoembolization for Recurrence Prediction of Hepatocellular Carcinoma in Living Donor Liver Transplantation.

C. Cho, K. Kim, S. Kim, J. Lee, J. Lee, J. Kim, G.-S. Choi, C. Kwon, J.-W. Joh, N. Lee.

Poster Session A: Living Donor Liver Transplantation  •  Halls C&D
5:30pm-7:30pm
CoCl2 Induced ER Stress Protein Mediated Cytotoxicity in FK506 Treated Hepatoma HepG2 Cells.

S. Choi, S. Chung.

Poster Session A: B cells & AMR, Alloreactivity, Immune Regulation & Regulatory T Cells, T Cell Biology and Alloreactivity, Immunesuppression  •  Halls C&D
5:30pm-7:30pm
Cold Ischemia Induced Outcomes in Kidney Transplantation: A Meta-Analysis.

D. Bennett, M. Mustafa, M. Chiles, W. Skillen, S. Mohan.

Poster Session A: Long Term Outcomes in Kidney Transplantation  •  Halls C&D
5:30pm-7:30pm
Comparative Analysis of Patients with Mixed Hepatocellular-Cholangiocarcinoma (HCC-CCA) Undergoing Liver Transplantation: A Single Center Matched Cohort Analysis.

K. Lunsford, M. Harlander-Locke, J. Gornbein, A. Zarrinpar, F. Kaldas, H. Yersiz, D. Farmer, R. Busuttil, V. Agopian.

Poster Session A: Liver - Hepatocellular Carcinoma and Cholangiocarcinoma Malignancies  •  Halls C&D
5:30pm-7:30pm
Comparison of Efficacy and Safety of a 4-Month Post-Renal Transplant Dose Reduction of Tacrolimus.

P. Gatault,1 N. Kamar,2 M. Buchler,1 C. Colosio,3 D. Bertrand,4 A. Durrbach,5 L. Albano,6 J. Rivalan,7 M. Essig,8 Y. Le Meur,9 N. Bouvier,10 B. Charpentier,5 E. Thervet,11 L. Rostaing,2 Y. Lebranchu.1

Poster Session A: Kidney: Acute Cellular Rejection  •  Halls C&D
5:30pm-7:30pm
Comparison of Once-Daily and Twice-Daily Low-Dose Tacrolimus in Living Related Kidney Transplantation – Prospective Trial of Once-Daily vs. Twice-Daily Tac – 5 Years Second Report.

T. Tsuchiya, H. Ishida, T. Nozaki, H. Shirakawa, T. Shimizu, K. Omoto, M. Okumi, K. Tanabe.

Poster Session A: Poster Session III: Kidney Complications-Other  •  Halls C&D
5:30pm-7:30pm
Comparison of Outcomes from Patients with Completion versus Total Pancreatectomy with Islet Autotransplantation: A Single-Institution Experience with 120 Consecutive Cases.

G. Yoshimatsu,1 M. Takita,1 R. Shahbazov,2 M. Lawrence,1 B. Naziruddin,3 P. Kim,3 M. Levy,4 N. Onaca.3

Poster Session A: Clinical Pancreas Transplantation and All Islet Cell Transplantation Topics  •  Halls C&D